Induction of Fetal Hemoglobin In Vivo Mediated by a Synthetic γ-Globin Zinc Finger Activator. - Wikidata - awgldk - TriplyDB

Induction of Fetal Hemoglobin In Vivo Mediated by a Synthetic γ-Globin Zinc Finger Activator.

Induction of Fetal Hemoglobin In Vivo Mediated by a Synthetic γ-Globin Zinc Finger Activator.

http://www.wikidata.org/entity/Q42217451

about

The potential of gene therapy approaches for the treatment of hemoglobinopathies: achievements and challenges Synthetic zinc finger proteins: the advent of targeted gene regulation and genome modification technologies.UtroUp is a novel six zinc finger artificial transcription factor that recognises 18 base pairs of the utrophin promoter and efficiently drives utrophin upregulation.Original Research: Generation of non-deletional hereditary persistence of fetal hemoglobin β-globin locus yeast artificial chromosome transgenic mouse models: -175 Black HPFH and -195 Brazilian HPFH Artificial zinc finger DNA binding domains: versatile tools for genome engineering and modulation of gene expression.Recent trends for novel options in experimental biological therapy of β-thalassemia.Recent trends in the gene therapy of β-thalassemia.Use of genome-editing tools to treat sickle cell disease.2017 Clinical trials update in new treatments of β-thalassemia.Piceatannol: a potential futuristic natural stilbene as fetal haemoglobin inducer.A Potential New Therapeutic Approach for Friedreich Ataxia: Induction of Frataxin Expression With TALE Proteins.Fetal haemoglobin induction in sickle cell disease.Comparison of MicroRNAs Mediated in Reactivation of the γ-Globin in β-Thalassemia Patients, Responders and Non-Responders to Hydroxyurea.TRIAMF: A New Method for Delivery of Cas9 Ribonucleoprotein Complex to Human Hematopoietic Stem Cells

P2860

Q28077484-8C4911C3-DB24-4822-BE1E-9F1E1DE2A72C Q34070213-AB2E7960-9763-4A45-BB6F-B5B90725BDDE Q34567478-6656B7F3-0CDE-4750-BCBF-0E6256DA0C82 Q36913598-AD5E1CEC-823D-479B-A20A-C8954C102F6C Q36951105-C4975047-53EC-482E-9CBA-99E353F2BF7E Q38220695-3A58E4BF-7D61-4BF9-BD7D-7CB3673DBD6D Q38367473-6DD4EB6A-0F18-4F0A-ABF3-6287D2BA2D1D Q38850483-DD81202A-3504-4DFA-9B1D-DA29FB87CC95 Q38922283-01B00C98-6EB2-4255-BD42-9697C86756F3 Q39248188-708869EA-8A5A-4AAF-9EF3-8D672AB0836C Q39793086-6A1ACED4-E25B-4D0B-8852-014857FF4794 Q45874514-AD045DAF-3FB7-45F7-B844-771491B34A48 Q50897207-A17EB510-5CBF-42E7-8982-6762A5BB0A51 Q58618192-219F33B4-372B-4270-8A9D-3BA0FEF906F8

P2860

Induction of Fetal Hemoglobin In Vivo Mediated by a Synthetic γ-Globin Zinc Finger Activator.

http://www.wikidata.org/entity/Q42217451

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Induction of Fetal Hemoglobin ...... -Globin Zinc Finger Activator.

@en

Induction of Fetal Hemoglobin ...... -Globin Zinc Finger Activator.

@nl

type

label

Induction of Fetal Hemoglobin ...... -Globin Zinc Finger Activator.

@en

Induction of Fetal Hemoglobin ...... -Globin Zinc Finger Activator.

@nl

prefLabel

Induction of Fetal Hemoglobin ...... -Globin Zinc Finger Activator.

@en

Induction of Fetal Hemoglobin ...... -Globin Zinc Finger Activator.

@nl

P1433

Q42217451-D3FAF88A-59A4-461B-A864-1B8CB746F031

P1476

Q42217451-C762972C-6AF7-4700-992C-AD8FB80689F2

P2093

Q42217451-65B92EEF-544F-4B86-9C41-3BB71140DEBB

Q42217451-6E660AC3-E388-40BF-A650-EDB33046F319

Q42217451-80265314-4929-4F4B-B923-5D463E4B79D9

Q42217451-A8D507D9-23FB-43A2-BE6A-20819E01FA89

Q42217451-CC16E769-E660-4260-8991-555B110AD902

Q42217451-D637E8DF-AF1E-4073-AE48-D211AA96F82C

P2860

Q42217451-067D6576-A832-4E7A-8159-6D1859D528C5

Q42217451-06A75A4D-5FFA-4149-ABDB-69ED62DFB799

Q42217451-0AB2A59F-0B60-4202-B8ED-E0666ECB864B

Q42217451-0CCB1FA9-680D-411B-B9BC-77701909EF9D

Q42217451-20806465-3FC7-4FFD-88A6-F924C1862C96

Q42217451-21188AF2-BCE2-4BBD-8613-189394261F03

Q42217451-27F2CE75-576A-438A-8D3B-43C0A765BCD2

Q42217451-2800E128-6613-44A3-9169-A43ED464A1A3

Q42217451-2FDF8414-2674-4635-8E30-8633EEE6ECDE

Q42217451-406E594D-E8B9-4361-B59E-E1A2FCBF7EFB

P304

Q42217451-91E21B29-2E06-4E21-9FE5-A86B15E05724

P31

Q42217451-4372E2B6-29A0-4A0F-908A-58916E016230

P356

Q42217451-882A3032-0D80-4848-8402-E59A06EE3D30

P478

Q42217451-D51F3EFB-A64E-497A-A920-6F95F3D86F75

P577

Q42217451-289D92D5-320E-4A3F-A5E2-6147074D361F

P5875

Q42217451-C3A2B5B3-8008-468F-80D1-34B75C5224B1

P698

Q42217451-F0738A1C-365F-41AF-BC7B-EE0B111CFE5E

P932

Q42217451-7A8B5F00-71B6-4709-B7AD-F9B10486BC6C

P356

P1433

P1476

Induction of Fetal Hemoglobin ...... -Globin Zinc Finger Activator.

@en

P2093

Carlos F Barbas

http://www.w3.org/2001/XMLSchema#string

Flávia C Costa

http://www.w3.org/2001/XMLSchema#string

Halyna Fedosyuk

http://www.w3.org/2001/XMLSchema#string

Johana Bravo de Los Rios

http://www.w3.org/2001/XMLSchema#string

Kenneth R Peterson

http://www.w3.org/2001/XMLSchema#string

Renee Neades

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic documentation and analysis of human genetic variation in hemoglobinopathies using the microattribution approach

{gamma}-Globin gene expression in chemical inducer of dimerization (CID)-dependent multipotential cells established from human {beta}-globin locus yeast artificial chromosome ({beta}-YAC) transgenic mice

Positive and negative regulation of endogenous genes by designed transcription factors

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

A new mathematical model for relative quantification in real-time RT-PCR

Positive selection of DNA-protein interactions in mammalian cells through phenotypic coupling with retrovirus production.

Adult stage gamma-globin silencing is mediated by a promoter direct repeat element.

A zinc-finger transcriptional activator designed to interact with the gamma-globin gene promoters enhances fetal hemoglobin production in primary human adult erythroblasts

Genome architecture of the human beta-globin locus affects developmental regulation of gene expression

Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment.

P304

507894

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/507894

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229017881

http://www.w3.org/2001/XMLSchema#string

P698

22778925

http://www.w3.org/2001/XMLSchema#string

P932

3384929

http://www.w3.org/2001/XMLSchema#string